Blood glucose in acute stroke

Expert Review of Neurotherapeutics

Volumn 9, Issue 3, 2009, Pages 409-419

  Olsen, Tom Skyhøj ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Diabetes mellitus; Glucose; Hyperglycemia; Outcome; Stroke

Indexed keywords

ALTEPLASE; GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

BLOOD CLOT LYSIS; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN INFUSION; MORTALITY; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; RISK FACTOR; STROKE; STROKE PATIENT; ARTICLE; BLOOD; PRACTICE GUIDELINE; TIME;

BLOOD GLUCOSE; BRAIN INJURIES; GUIDELINES AS TOPIC; HUMANS; HYPOGLYCEMIC AGENTS; STROKE; TIME FACTORS;

EID: 66449131186     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.9.3.409     Document Type: Review

References (71)

1. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32, 2426-2432 (2001).
2. Moustafa RR, Baron J-C. Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery. Br. J. Pharmacol. 153, S44-S54 (2008).
3. Jorgensen HS, Sperling B, Nakayama H, Raaschou Olsen TS. Spontaneous reperfusion of cerebral infarcts in acute stroke patients. Incidence, time course and clinical outcome: the Copenhagen Stroke Study. Arch. Neurol. 51, 865-873 (1994).
4. Neumann-Haefelin T, du Mesnil de Rochemont R, Fiebach JB et al. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusiona magnetic resonance imaging study. Stroke 35(1), 109-115 (2004).
5. Bowler JV, Wade JPH, Jones BE, Nijran KS, Steiner TJ. HMPAO SPECT human cerebral infarcts as assessed by 99mTc. J. Neurol. Neurosurg. Psychiatry 64, 90-97 (1998).
6. Aur RN, Siesjö B. Biological differences between ischemia, hypoglycemia and epilepsy. Ann. Neurol. 24, 699-707 (1988).
7. Pulsinelli WA, Waldman S, Rawlinson D, Plum F. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology 32, 1239-1246 (1982).
8. Rehncrona S, Rosen I, Siesjo BK. Brain lactic acidosis and ischemic cell damage: 1. Biochemistry and neurophysiology. J. Cereb. Blood Flow Metab. 1, 297-311 (1981).
9. Kawai N, Keep RF, Betz AL. Effects of hyperglycemia on cerebral blood flow and edema formation after carotid artery occlusion in Fischer 344 rats. Acta Neurochir. 70(Suppl. 2), 34-36 (1997).
10. Dietrich TO, Alonso O, Busto R. Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke 24, 111-116 (1993).
11. de Courten-Myers GM, Kleinholz M, Holm P, Schmitt G, Wagner KR, Myers RE. Hemorrhagic infarct conversion in experimental stroke. Ann. Emerg. Med. 21, 120-125 (1992).
12. Vriensendorp TM, DeVries JH, Hoekstra JBL. Hypoglycemia and strict glycemic control in critically ill patients. Curr. Opin. Crit. Care 14, 397-402 (2008).
13. de Courten-Myers GM, Kleinholz M, Wagner KR, Myers RE. Fatal strokes in hyperglycemic cats. Stroke 20, 1707-1715 (1989).
14. Prado R, Ginsberg MD, Dietrich WD, Watson BD, Busto R. Hyperglycemia increases infarct size in collaterally perfused but not end-arterial vascular territories. J. Cereb. Blood Flow Metab. 8, 186-192 (1988).
15. Kawai N, Keep RF, Betz AL. Hyperglycemia and the vascular effects of cerebral ischemia. Stroke 28, 149-154 (1997).
16. Ginsberg MD, Prado R, Dietrich WD, Busto R, Watson BD. Hyperglycemia reduces the extent of cerebral infarction in rats. Stroke 18, 570-574 (1987).
17. Nedergaard M, Gjedde A, Diemer NH. Hyperglycemia protects against neuronal injury around experimental brain infarcts. Neurol. Res. 9, 241-244 (1987).
18. Zasslow MA, Pearl RG, Shuer LM, Steinberg GK, Lieberson RE, Larson CPJ. Hyperglycemia decreases acute neuronal ischemic changes after middle cerebral artery occlusion in cats. Stroke 20, 519-523 (1989).
19. Kraft SA, Larson CPJ, Shuer LM, Steinberg GK, Benson GV, Pearl RG. Effect of hyperglycemia on neuronal changes in a rabbit model of focal cerebral ischemia. Stroke 21, 447-450 (1990).
20. Combs DJ, Dempsey RJ, Kumar S, Donaldson D. Focal cerebral infarction in cats in the presence of hyperglycemia and increased insulin. Metab. Brain Dis. 5, 169-178 (1990).
21. Voll C, Auer R. The effect of postischemic blood glucose levels on ischemic brain damage in the rat. Ann. Neurol. 24, 638-646 (1988).
22. Parsons MW, Barber PA, Desmond PM et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann. Neurol. 52, 20-28 (2002).
23. Baird TA, Parsons MW, Phanh T et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 34, 2208-2214 (2003).
24. Alvarez-Sabin J, Molina CA, Montaner J etal. Effects of admission hyperglycemia on strokeoutcome in reperfused tissue plasminogen activator-treated patients. Stroke 34, 1235-1241 (2003).
25. Williams LS, Rotich J, Qi R et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 59, 67-71 (2002).
26. Yong M, Kaste M. Dynamic of Hyperglycemia as a predictor of stroke outcome in the ECASS-II trial. Stroke 39, 2749-2755 (2008).
27. Allport LE, Baird TA, Butcher KS et al. Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care 29, 1839-1844 (2006).
28. Bruno A, Levine SR, Frankel MR et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 59, 669-674 (2002).
29. Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes: the Copenhagen Stroke Study. Stroke 25, 1977-1984 (1994).
30. Gray C, Hildreth A, Sandercock P et al.; for the GIST Trialists Collaboration. Glucose-potassium-insulin infusions in the management of post stroke hyperglycaemia. The United Kingdom Glucose Insulin in Stroke Trial (GIST-UK): a randomised controlled trial. Lancet Neurol. 6, 397-406 (2007).
31. Walters MR, Weir CJ, Lees K. A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischemic stroke patients. Cerebrovasc. Dis. 22, 116-122 (2006).
32. Christensen H, Boysen G. Blood glucose increases early after stroke onset: a study on serial measurements of blood glucose in acute stroke. Eur. J. Neurol. 9, 297-301 (2002).
33. Wong AA, Schluter PJ, Henderson RD, O'Sullivan JD, Read SJ. Natural history of blood glucose within the first 48 hours after ischemic stroke. Neurology 70, 1036-1041 (2008).
34. Stead LG, Rachel GM. Gilmore RM et al. Hyperglycemia as an independent predictor of worse outcome in non-diabetic patients presenting with acute ischemic stroke. Neurocrit. Care DOI: 10.1007/s12028-008-9080-9080 (2008) (Epub ahead of print).
35. Scott JF, Robinson GM, French JM et al. Prevalence of admission hyperglycemia across clinical subtypes of acute stroke. Lancet 353, 376-377 (1999).
36. Passero S, Ciacci G, Ulivelli M. The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. Neurology 61, 1351-1356 (2003).
37. Franke CL, van Swieten JC, Algra A, van Gijn J. Prognostic factors in patients with intracerebral hematoma. J. Neurol. Neurosurg. Psychiatry 55, 653-657 (1992).
38. Fogelholm R, Murros K, Rissanen A, Avikainen S. Admission blood glucose and short term survival in primary intracerebral hemorrhage: a population based study. J. Neurol. Neurosurg. Psychiatry 76, 349-353 (2005).
39. Kimura K, Iguchi Y, Inoue T et al. Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage. J. Neurol. Sci. 255, 90-94 (2007).
40. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycemia an independent predictor of poor outcome after stroke? Results of a long term follow up study. BMJ 314, 1303-1306 (1997).
41. Bruno A, Biller J, Adams HP Jr et al. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 52, 280-284 (1999).
42. van Kooten F, Hoogerbrugge N, Naarding P, Koudstaal PJ. Hyperglycemia in the acute phase of stroke is not caused by stress. Stroke 24, 1129-1132 (1993).
43. Candelise L, Landi G, Orazio EN, Boccardi E. Prognostic significance of hyperglycemia in acute stroke. Arch. Neurol. 42, 661-663 (1985).
44. O'Neill PA, Davies I, Fullerton KJ, Bennett D. Stress hormone and blood glucose response following acute stroke in the elderly. Stroke 22, 842-847 (1991).
45. Tracey F, Crawford VL, Lawson JT, Buchanan KD, Stout RW Hyperglycaemia and mortality from acute stroke. QJ Med. 86, 439-446 (1993).
46. Murros K, Fogelholm R, Kettunen S, Vuorela AL. Serum cortisol and outcome of ischemic brain infarction. J. Neurol. Sci. 116, 12-17 (1993).
47. The NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl. J. Med. 333, 1581-1587 (1995).
48. Els T, Klisch J, Orszagh M et al. Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size. Cerebrovasc. Dis. 13, 89-94 (2002).
49. Ribo M, Molina CA, Delgado P et al. Hyperglycaemia during ischaemia rapidly accelerates brain damage in stroke patients treated with tPa. J. Cereb. Blood Flow Metabol. 27, 1616-1622 (2007).
50. Ribo M, Molina C, Montaner J et al. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke 56, 1705-1709 (2005).
51. Wahlgren N, Ahmed N, Davalos A et al. Thrombolysis with alteplase for acute ischaemic stroke in Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369, 275-282 (2007).
52. Lansberg MG, Albers GW, Wijman CAC. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc. Dis. 24, 1-10 (2007).
53. Van den Berghe G, Wouters PJ, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl. J. Med. 345, 1359-1367 (2001).
54. Malmberg K, Ryden L, Efendic S et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J. Am. Coll. Cardiol. 26, 57-65 (1995).
55. Pittas AG, Siegel RD, Lau J. Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials. J. Parenter. Enteral Nutr. 30, 164-172 (2006).
56. Malmberg K, Rydén L, Wedel H et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur. Heart J. 26, 650-661 (2005).
57. The Action to Control Cardiovasular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl. J. Med. 358, 2545-2549 (2008).
58. Van den Berghe G, Wilmer A, Hermans G et al. Intensive insulin therapy in the medical ICU. N Engl. J. Med. 354, 449-461 (2006).
59. The CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin- potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction. JAMA 293, 437-446 (2005).
60. Devos P, Preiser JC, Melot C; for the Glucontrol Steering Committee: Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study. Intensive Care Med. 33, S189 (2007).
61. Brunkhorst FM, Engel C, Bloos F et al. Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis. N. Engl. J. Med. 358, 125-139 (2008).
62. Treggiari MM, Karir V, Yanez ND, Weiss NS, Daniel S, Deem SA. Intensive insulin therapy and mortality in critically ill patients. Crit. Care 12(1), R29 (2008).
63. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults. A metaanalysis. JAMA 300, 933-944 (2008).
64. Braatvedt GD. Glucose control peri-myocardial infarction. Int. Med. J. 38, 341-344 (2008).
65. Gandhi GY, Nuttall GA, Abel MD et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Ann. Intern. Med. 146, 233-243 (2007).
66. Finfer S, Delaney A. Tight glycemic control in critically ill adults. JAMA 300, 963-965 (2008).
67. Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352, 1245-1251 (1998).
68. Walters MR, Weir CJ, Lees KR. A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute stroke patients. Cerebrovasc. Dis. 22, 116-122 (2006).
69. Bruno A, Kent T, Coull BM et al. Treatment of hyperglycemia in ischemic stroke (THIS). A randomized pilot trial. Stroke 39, 384-389 (2008).
70. Adams HP Jr, del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association J. American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke 38, 1655-1711 (2007).
71. Gray CS, Hildreth AJ, Alberti GKMM, O'Connell JE. Poststroke hyperglycemia natural history and immediate management. Stroke 35, 122-126 (2004).